| Dr Ricardo E Colberg, MD | |
|
805 Saint Vincents Dr Ste 100, Birmingham, AL 35205-1638 | |
| (205) 939-3699 | |
| (205) 581-7155 |
| Full Name | Dr Ricardo E Colberg |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 805 Saint Vincents Dr Ste 100, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073760831 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 31582 (Alabama) | Secondary |
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 31582 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stv Sports Medicine And Orthopedics Llc | 0446554562 | 42 |
News Archive
There are potential legal ramifications for physicians of patients who drive with cognitive impairment, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
While legions of medical researchers have been looking to understand the genetic basis of disease and how mutations may affect human health, a group of biomedical researchers at UC Santa Barbara is studying the metabolism of cells and their surrounding tissue, to ferret out ways in which certain diseases begin.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
The University of Louisville is one of nine pilot sites selected by the Pulmonary Fibrosis Foundation for its newly established Care Center Network and the PFF Patient Registry program. Rafael Perez, M.D., director of the UofL Interstitial Lung Disease program in the Division of Pulmonary, Critical Care & Sleep Disorders Medicine, will lead the UofL site.
› Verified 5 days ago
| Entity Name | Andrews Sports Medicine And Orthopaedic Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679617526 PECOS PAC ID: 1850482100 Enrollment ID: O20070801000349 |
News Archive
There are potential legal ramifications for physicians of patients who drive with cognitive impairment, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
While legions of medical researchers have been looking to understand the genetic basis of disease and how mutations may affect human health, a group of biomedical researchers at UC Santa Barbara is studying the metabolism of cells and their surrounding tissue, to ferret out ways in which certain diseases begin.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
The University of Louisville is one of nine pilot sites selected by the Pulmonary Fibrosis Foundation for its newly established Care Center Network and the PFF Patient Registry program. Rafael Perez, M.D., director of the UofL Interstitial Lung Disease program in the Division of Pulmonary, Critical Care & Sleep Disorders Medicine, will lead the UofL site.
› Verified 5 days ago
| Entity Name | Stv Sports Medicine & Orthopedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467818575 PECOS PAC ID: 0446554562 Enrollment ID: O20160210002722 |
News Archive
There are potential legal ramifications for physicians of patients who drive with cognitive impairment, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
While legions of medical researchers have been looking to understand the genetic basis of disease and how mutations may affect human health, a group of biomedical researchers at UC Santa Barbara is studying the metabolism of cells and their surrounding tissue, to ferret out ways in which certain diseases begin.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
The University of Louisville is one of nine pilot sites selected by the Pulmonary Fibrosis Foundation for its newly established Care Center Network and the PFF Patient Registry program. Rafael Perez, M.D., director of the UofL Interstitial Lung Disease program in the Division of Pulmonary, Critical Care & Sleep Disorders Medicine, will lead the UofL site.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ricardo E Colberg, MD 805 Saint Vincents Dr Ste 100, Birmingham, AL 35205-1638 Ph: (205) 939-3699 | Dr Ricardo E Colberg, MD 805 Saint Vincents Dr Ste 100, Birmingham, AL 35205-1638 Ph: (205) 939-3699 |
News Archive
There are potential legal ramifications for physicians of patients who drive with cognitive impairment, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
While legions of medical researchers have been looking to understand the genetic basis of disease and how mutations may affect human health, a group of biomedical researchers at UC Santa Barbara is studying the metabolism of cells and their surrounding tissue, to ferret out ways in which certain diseases begin.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
The University of Louisville is one of nine pilot sites selected by the Pulmonary Fibrosis Foundation for its newly established Care Center Network and the PFF Patient Registry program. Rafael Perez, M.D., director of the UofL Interstitial Lung Disease program in the Division of Pulmonary, Critical Care & Sleep Disorders Medicine, will lead the UofL site.
› Verified 5 days ago
Charles R Law, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 120 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3944 Fax: 205-413-4914 | |
Keneshia Kirksey, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Charles Carnel, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 805 Saint Vincents Dr, Birmingham, AL 35205 Phone: 205-939-3699 Fax: 205-581-7155 | |
Lonnie Blake Dorcey, RPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1201 3rd Ave N Ste B, Birmingham, AL 35203 Phone: 256-546-8127 Fax: 256-547-6720 | |
Dr. Srinivas Mallempati, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1801 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3900 Fax: 205-838-3906 | |
Elizabeth Chantal Twist, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Leesa D Miles, RPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 4th Ave S, Birmingham, AL 35233 Phone: 205-263-5800 Fax: 205-263-5850 |